IGFBP-3, one of the major members of the insulin-like growth factor binding protein family, has growth inhibitory effects in vitro (56)
A difference of even 1020 units on a syringe can represent a 2550% deviation from your target dose depending on concentration
Ayadi, Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study, Altern
Hydroxocobalamin 20 mg/ml Injection Solution may also interact with certain laboratory tests, such as blood tests and urine tests
BPC-157, or Body Protection Compound-157, is a synthetic pentadecapeptide
A provider should reassess progress, side effects, hormone markers, metabolic health, and whether the peptide should be continued, adjusted, paused, or stopped